New survey on access to HIV prevention and treatment among MSM

NewsGuard 100/100 Score
Jul 14 2011

A new survey (.pdf) of more than 5,000 men who have sex with men (MSM), conducted by the Global Forum on MSM & HIV (MSMGF), "has shown that less than half of MSM around the world have easy access to lifesaving HIV prevention and treatment services," according to an MSMGF press release. The global survey shows "[s]ignificant disparities in levels of access, knowledge and homophobia … between regions," the release states (7/12).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Men's Health News | Healthcare News

    Tags: , , , ,

    Comments (0)

    Suggested Reading

    Unveiling the key role of RNA modification in HIV-1 survival and replication
    New drug candidates show promise to reverse HIV immune evasion
    Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies
    Breakthrough study offers hope for an effective HIV cure
    Researchers receive NIH grant to help develop gene therapy for HIV
    Researchers develop precise drugs to target HIV's Nef protein
    New report on HIV drug resistance: Challenges and recommendations
    Common HIV drugs linked to reduced Alzheimer's disease risk

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    U-M research offers a new path forward in the development of anti-HIV drugs